Man survives 48 hours without lungs before transplant

A 33-year-old man endured 48 hours without lungs after surgeons removed his severely infected ones to halt a deadly infection. An artificial lung system kept him alive until a double lung transplant could be performed. More than two years later, he lives a normal life with healthy lung function.

A critically ill 33-year-old man arrived at Northwestern University with acute respiratory distress syndrome (ARDS) triggered by the flu and complicated by bacterial pneumonia. His lungs, heart, and kidneys were failing. 'He was critically ill. His heart stopped as soon as he arrived. We had to perform CPR,' said lead author Ankit Bharat, a thoracic surgeon at the university. The infection had destroyed his lungs beyond repair, actively spreading to other organs. Doctors decided to remove both lungs entirely to stop the spread, but his body was too unstable for an immediate transplant. In their place, the team deployed a specially engineered artificial lung system. This device oxygenated his blood, removed carbon dioxide, and supported circulation. 'The heart and lungs are intrinsically connected,' Bharat explained. 'When there are no lungs, how do you keep the patient alive?' After the pneumonectomy, his blood pressure stabilized, organs began recovering, and the infection was controlled. Exactly 48 hours later—two days after surgery—donor lungs became available, enabling a successful double lung transplant. Molecular analysis of the removed lungs revealed extensive scarring and immune system damage, providing 'biological proof' that they could not recover. 'For the first time, biologically, we are giving molecular proof that some patients will need a double lung transplant, otherwise they will not survive,' Bharat stated. The case, detailed in the journal Med from Cell Press, suggests this approach as a potential bridge for patients with irreversible acute lung damage from infections. Bharat noted that young patients often die weekly without recognizing transplantation as an option.

Related Articles

Detroit Pistons guard Cade Cunningham clutches his chest in pain on the court after suffering a collapsed lung during a game.
Image generated by AI

Pistons star Cade Cunningham diagnosed with collapsed lung

Reported by AI Image generated by AI

Detroit Pistons guard Cade Cunningham has suffered a collapsed left lung and will be re-evaluated in two weeks. The injury occurred during Tuesday's win over the Washington Wizards, initially reported as a back contusion. The team hopes for his return in time for the playoffs starting April 18.

The suicide of Luiz Phillipi Machado de Moraes Mourão, arrested in Operation Compliance Zero, sparked confusion over brain death. Experts clarify that suspicion does not equal diagnosis, which requires a rigorous protocol endorsed by the Federal Council of Medicine. The process confirms the irreversibility of total brain function loss.

Reported by AI

A study published on Monday in Nature Microbiology confirms long-term HIV remission in the «Oslo patient», a 62-year-old man treated for myelodysplasia via stem cell transplant from his brother carrying the CCR5 Delta 32 mutation. He has been off antiretrovirals for four years with no detectable virus. This brings the total to ten patients deemed cured this way.

Researchers at Stanford Medicine have created an experimental nasal spray vaccine that protects mice against multiple respiratory threats, including COVID-19, flu, bacterial pneumonia, and allergens. The vaccine activates the lungs' innate immune system for months, offering broad defense without targeting specific pathogens. Published in Science on February 19, the study suggests potential for human trials soon.

Reported by AI

New research indicates that severe cases of COVID-19 or influenza can alter lung immune cells, potentially increasing cancer risk months or years afterward. The study, conducted by scientists at the University of Virginia, highlights the role of chronic inflammation in this process and emphasizes vaccination as a preventive measure. Findings suggest closer monitoring for affected patients to enable early detection.

Researchers at the University of California, San Francisco have identified how aging lungs contribute to severe flu and COVID-19 outcomes in older adults. Their study shows that lung fibroblasts trigger excessive inflammation, forming damaging clusters of immune cells. The findings, published in Immunity on March 27, suggest potential new treatments.

Reported by AI

Kabir Mohan quit his travel agency business to become a full-time caregiver for his wife Chhanda, who battles chronic kidney disease and relies on dialysis. Chhanda is a heart attack survivor, and their daughter is autistic. Kabir has ensured family stability through careful financial planning and medical adherence.

 

 

 

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline